Wolters Kluwer Law & Business is a leading provider of research products and software solutions in key specialty areas for legal and business professionals, as well as casebooks and study aids for law students.
Wolters Kluwer Law & Business is the new identity for all CCH Corporate Counsel products. We will continue to be the premier provider of authoritative, timely and comprehensive Corporate Counsel information. For over 80 years, CCH has set the standard for research and compliance tools for attorneys, health care professionals, corporations and government agencies. Its products and services are considered the leading resources for corporate counsel.
Our major product lines include Aspen Publishers, CCH, Kluwer Law International and Loislaw. Key specialty areas include:
Our markets include law firms, law schools, corporate counsel and professionals requiring legal and compliance information.
Wolters Kluwer's global scope and greater depth of industry expertise mean you can expect the same caliber of resources you've always enjoyed, and look forward to new and innovative products yet to come.
Wolters Kluwer Law & Business, a unit of Wolters Kluwer, is based in New York City and Riverwoods, Ill.
Wolters Kluwer is a leading multinational publisher and information services company. The Company's core markets are health, corporate services, financial services, tax, accounting, legal, regulation, and education. Wolters Kluwer has annual revenues (2005) of €3.4 billion, employs approximately 18,400 people worldwide and maintains operations across Europe, North America and Asia Pacific. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its depositary receipts of shares are quoted on the Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. For more information, see www.wolterskluwer.com.
SEC Deputy Director Shelley Parratt urged companies not to wait for staff comments to improve their compensation discussion and analysis ("CD&A"). After three years of comments on how to improve their disclosure, Parratt said companies now should be prepared to amend their filings if they do not materially comply with the rules.
Insights into legislative activity, cases of note, and other breaking news.
Insights and commentary on health reform.
A forum to discuss antitrust and trade regulation law.
Commentary and musings about securities regulation.